Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Nagase (Tokyo, Japan), J. Tamaoki (Tokyo, Japan), T. Suzuki (Tokyo, Japan), Y. Nezu (Tokyo, Japan), A. Cole (Collegeville, United States of America), S. Yang (Collegeville, United States of America), G. Mu (Collegeville, United States of America), M. Katsumata (Tokyo, Japan), M. Komatsubara (Tokyo, Japan), R. Alfonso (Collegeville, United States of America). Effectiveness of Mepolizumab in Reducing Asthma Exacerbations in Japan. 2219

Member's Comments

No comment yet.

Related content which might interest you: Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Exacerbations of Asthma Source: Eur Respir J 2007; 29: 1071 Year: 2007 Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Evaluation of Asthma control and oral corticosteroids in Severe Asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Guideline Adherence and Identifying Cost Effective Medication Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Co-Morbidities Are Serious Confounders of Asthma in Severe Asthma Source: Research Seminar 2007 - Severe Asthma Year: 2007 Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Predictors of exacerbations in asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Use of β-blockers and the risk of asthma exacerbations Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018 How to Manage Severe Asthma, the Value of Inflammation Monitoring Source: Research Seminar 2007 - Severe Asthma Year: 2007 Study of Efficacy of Sublingual Immunotherapy in Cases Asthma & Allergic Rhinitis in India Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma Source: International Congress 2018 – Asthma analysis Year: 2018 Assessment of Severe Asthma Management Practices among Pulmonologists and Allergists Source: International Congress 2018 – Medical education via the web and the internet Year: 2018